ABIOMED, Inc. · Danvers, MA United States (NASDAQ: ABMD)
Key ABIOMED, Inc. Financials
| Company Type | Public -(NASDAQ: ABMD) Headquarters |
|---|---|
| Fiscal Year-End | March |
| 2011 Sales (mil.) | $101.2 |
| 2011 Employees | 374 |
ABIOMED, Inc. Income Statement
| Mar 11 | Mar 10 | Mar 09 | |
| Revenue | 101.2 | 85.7 | 73.2 |
| Cost of Goods Sold | 22.0 | 22.5 | 20.4 |
| Gross Profit | 79.2 | 63.2 | 52.8 |
| Gross Profit Margin | 78.3% | 73.7% | 72.1% |
| SG&A Expense | 62.3 | 60.8 | 55.4 |
| Depreciation & Amortization | 1.4 | 1.5 | 1.6 |
| Operating Income | (11.2) | (25.1) | (29.5) |
| Operating Margin | -11.1% | -29.3% | -40.3% |
| Nonoperating Income | 0.3 | 6.7 | (1.3) |
| Nonoperating Expenses | -- | -- | -- |
| Income Before Taxes | (10.9) | (18.4) | (30.8) |
| Income Taxes | 0.9 | 0.7 | 0.8 |
| Net Income After Taxes | (11.8) | (19.0) | (31.6) |
| Continuing Operations | (11.8) | (19.0) | (31.6) |
| Discontinued Operations | -- | -- | -- |
| Total Operations | (11.8) | (19.0) | (31.6) |
| Total Net Income | (11.8) | (19.0) | (31.6) |
| Net Profit Margin | -11.6% | -22.2% | -43.2% |
| Diluted EPS from Total Net Income | (0.32) | (0.52) | (0.91) |
| Dividends per Share | -- | -- | -- |
All amounts in millions of US Dollars except per share amounts.
ABIOMED, Inc. Balance Sheet
| Assets | Mar 11 | Mar 10 | Mar 09 |
| Current Assets | |||
| Cash | 5.8 | 4.8 | 1.8 |
| Net Receivables | 15.4 | 13.5 | 15.7 |
| Inventories | 7.5 | 9.2 | 14.8 |
| Other Current Assets | 56.0 | 55.2 | 56.2 |
| Total Current Assets | 84.7 | 82.7 | 88.5 |
| Net Fixed Assets | 6.3 | 6.8 | 7.8 |
| Other Noncurrent Assets | 40.6 | 40.1 | 39.7 |
| Total Assets | 131.6 | 129.6 | 136.0 |
| Liabilities | Mar 11 | Mar 10 | Mar 09 |
| Current Liabilities | |||
| Accounts Payable | 6.3 | 3.8 | 5.6 |
| Short-Term Debt | -- | -- | -- |
| Other Current Liabilities | 16.1 | 14.3 | 12.0 |
| Total Current Liabilities | 22.3 | 18.1 | 17.6 |
| Long-Term Debt | -- | -- | -- |
| Other Noncurrent Liabilities | 4.5 | 3.6 | 2.4 |
| Total Liabilities | 26.8 | 21.6 | 20.0 |
| Shareholder's Equity | |||
| Preferred Stock Equity | 0.0 | -- | 0.0 |
| Common Stock Equity | 104.7 | 108.0 | 116.0 |
| Total Equity | 104.7 | 108.0 | 116.0 |
| Shares Outstanding (thou.) | 37,705.8 | 37,433.1 | 36,686.6 |
All amounts in millions of US Dollars except per share amounts.
ABIOMED, Inc. Cash Flow Statement
| Mar 11 | Mar 10 | Mar 09 | |
| Net Operating Cash Flow | 2 | (7) | (18) |
| Net Investing Cash Flow | (2.4) | 8.8 | (26.8) |
| Net Financing Cash Flow | 1.4 | 1.0 | 46.2 |
| Net Change in Cash | 1.0 | 3.0 | (0.3) |
| Depreciation & Amortization | 1.4 | 1.5 | 1.6 |
| Capital Expenditures | (1.8) | (1.8) | (3.8) |
| Cash Dividends Paid |
All amounts in millions of US Dollars except per share amounts.